Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

iCrowdNewswire Nov 21, 2020 3:00 PM ET

Topical Drug Delivery Market to See Huge Growth by 2027 | Novartis, GlaxoSmithKline, Bausch Health


Topical Drug Delivery Market to See Huge Growth by 2027 | Novartis, GlaxoSmithKline, Bausch Health

iCrowd Newswire - Nov 21, 2020

A new research document is added in HTF MI database of 200 pages, titled as ‘Global Topical Drug Delivery Market by Type (Semisolids), Liquids, Solids, Transdermal Products), by Route of Administration (Dermal, Ophthalmic, Nasal), by Facility of Use (Homecare, Hospital, others) and Regional Forecasts 2020-2027’ with detailed analysis, Competitive landscape, forecast and strategies. Latest analysis highlights high growth emerging players and leaders by market share that are currently attracting exceptional attention.  The identification of hot and emerging players is completed by profiling 50+ Industry players; some of the profiled players are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India). The Market has witnessed continuous growth in the past few years and is projected to see some stability post Q2,2020 and may grow further during forecast year 2021-2026

Access sample report @ https://www.htfmarketreport.com/sample-report/2925020-global-topical-drug-delivery-market-by-type

Summary
The topical drug delivery  market size is valued approximately at USD 93.2 billion in 2019,and is expected to thrive at a CAGR of 5.7% over the forecast period 2020-2027.  Topical medications are preferable for local therapy and are applied on body surfaces such as skin and mucous membrane, they project good applicability and patient compliance. These medications include creams, foams, gels, lotions, ointments, and others. The high prevalence of skin and eye diseases, high incidence of burn injuries, psoriasis, eczema  and the growing prevalence of diabetes are the factors supporting for high end demand of topical products which in turn boost the global topical drug delivery market.  The innovations and developments taken by key market players in topical formulation is further going to boost the market. For instance, in December 2018, Cipher Pharmaceuticals Inc. (Canada) obtained approval for its “A-101, 40% topical solution” by Health Canada. This solution is used for treatment of facial SK lesions and target disease is seborrheic keratosis, which is a common type of non -carcinogenic skin outgrowth that nearly impact 9 million Canadian adults. Similarly, in December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing sites in Canada to increase the production and support logistics of its blockbuster product “VOLTAREN” which is a topical pain reliever. Furthermore, the rise in demand of topical route of administration, non-invasive nature and increase in population geriatric patients are few remunerative opportunities which is responsible for the growth of the market during the forecast period. However, technical barriers related to skin irritation and permeability of drug, drug failures and product recalls may subject hinderance and instability to the flourishing market.
The regional analysis of the topical drug delivery market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable funding for development of topical drugs and innovative topical formulations in the region, along with the presence of a significant number of skilled personnel in the region. Whereas Asia-Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027

Major market player included in this report are:
Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India)

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2925020-global-topical-drug-delivery-market-by-type

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product: Semi-solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products

By Route of Administration: Dermal Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery

By Facility of use: Homecare Settings, Hospitals & Clinics, Other Facilities (academic & research institutes and diagnostic centers)

By Region:
North America (United States, Canada, Mexico)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, Australia, China Taiwan, Rest of Asia-Pacific)

Europe (Germany, UK, France, Italy, Russia, Spain, Benelux, Rest of Europe)

South America (Brazil, Argentina, Colombia, Chile, Rest of South America)

Middle East & Africa (Saudi Arabia, Turkey, Egypt, South Africa, Rest of Middle East & Africa)

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2018
Forecast period – 2020-2027

Target Audience of the Global Topical drug delivery Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2925020-global-topical-drug-delivery-market-by-type

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2027(USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Topical Drug Delivery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Topical Drug Delivery Market Dynamics
3.1. Topical Drug Delivery Market Impact Analysis (2020-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Topical Drug Delivery Market Industry Analysis
4.1. Porter’s 5 Force Model
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Topical Drug Delivery Market, by type
5.1. Market Snapshot
5.2. Global Topical Drug Delivery Market by type, Performance – Potential Analysis
5.3. Global Topical Drug Delivery Market Estimates & Forecasts by type 2020-2027(USD Billion)
5.4. Topical Drug Delivery Market, Sub Segment Analysis
Chapter 6. Global Topical Drug Delivery Market, by route of administration
6.1. Market Snapshot
6.2. Global Topical Drug Delivery Market by route, Performance – Potential Analysis
6.3. Global Topical Drug Delivery Market Estimates & Forecasts by route 2020-2027(USD Billion)
6.4. Topical Drug Delivery Market, Sub Segment Analysis
Chapter 7. Global Topical Drug Delivery Market, by facility of use
7.1. Market Snapshot
7.2. Global Topical Drug Delivery Market by facility of use – Potential Analysis
7.3. Global Topical Drug Delivery Market Estimates & Forecasts by facility of use 2020-2027(USD Billion)
7.4. Topical Drug Delivery Market, Sub Segment Analysis
Chapter 8. Global Topical Drug Delivery Market, Regional Analysis
8.1. Topi

….Continued

Purchase Single User License of this report at USD4950@ https://www.htfmarketreport.com/buy-now?format=1&report=2925020

It’s vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

Contact Information:

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

Connect with us at LinkedIn | Facebook | Twitter






Keywords:    Topical Drug Delivery Market Analysis, Topical Drug Delivery Market Forecast, Topical Drug Delivery Market Growth, Topical Drug Delivery Market Share, Topical Drug Delivery Market Size, Topical Drug Delivery Market Trends

Tags:    Reportedtimes, iCN Internal Distribution, Research Newswire, English